Abstracts Presented at 41st Annual, 9th International Conference of the Islamic Medical Association of North America and First Joint Conference with the Federation of Islamic Medical Associations (FIMA), July 31-August 2, 2008

2008 ◽  
Vol 40 (3) ◽  
Author(s):  
IMANA Conference
Keyword(s):  
North America ◽  
Medical Association ◽  
Joint Conference ◽  
International Conference ◽  
Medical Associations

Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic

2012 ◽  
Vol 16 (2) ◽  
pp. 92-96
Author(s):  
Eiman Nasseri ◽  
Janie Bertrand ◽  
Danielle Brassard ◽  
Geneviève Fortier-Riberdy ◽  
Isabelle Marcil
Keyword(s):  
Medical Association ◽  
High Morbidity ◽  
Beliefs And Practices ◽  
Centre Hospitalier ◽  
National Medical ◽  
Dermatology Clinic ◽  
Medical Associations ◽  
Structured Approach ◽  
Case Basis

Background: Patient nonattendance is a frequent occurrence in dermatology clinics, and our responsibility regarding the follow-up of these patients remains nebulous. Objective: This study sought to evaluate the beliefs and practices of physicians at a university-affiliated medical dermatology clinic regarding patient nonattendance at follow-up appointments and to provide an algorithm to deal appropriately with absentee patients based on various Canadian medical association guidelines. Methods: A questionnaire was distributed to the 17 dermatologists practicing at the Centre Hospitalier de l'Université de Montréal medical dermatology clinic. We contacted provincial and national medical associations regarding directives for patient follow-up. Results: There is a lack of consensus among dermatologists at the Centre Hospitalier de l'Université de Montréal regarding responsibility toward patients who miss their follow-up appointments. However, the majority of survey respondents consider that patient follow-up must be adjusted on a case-by-case basis and that diagnoses at risk for high morbidity and mortality require particular attention, which is in line with various Canadian medical association guidelines. Conclusion: Dermatologists should have a structured approach to dealing with patients who miss their follow-up appointments to ensure the appropriate care of all patients.

scholarly journals P070: A systematic assessment of opioid-related advertisements aimed at emergency physicians in North America

CJEM ◽  
2020 ◽  
Vol 22 (S1) ◽  
pp. S89-S89
Author(s):  
A. Kirubarajan ◽  
A. Dragoman ◽  
J. Balakumaran ◽  
T. Got ◽  
N. Persaud ◽  
...  
Keyword(s):  
Emergency Medicine ◽  
North America ◽  
Medical Association ◽  
American Medical ◽  
Family Physician ◽  
North American ◽  
Conflicts Of Interest ◽  
Medical Journals ◽  
Levels Of Evidence ◽  
Medicine Journal

Introduction: The opioid epidemic has been influenced by immense marketing campaigns produced by pharmaceutical companies. These campaigns include advertisements aimed at emergency medicine (EM) physicians, which may have influenced overprescription. This study is a part of a larger effort to systematically assess opioid ads published in major medical journals in North America. To our knowledge, this is the first study to systematically assess the volume, claims, and levels of evidence for opioid ads aimed at EM physicians. Methods: Up to two issues per year from 1996 to 2016 of ten major North American medical journals were hand-searched for opioid advertisements. Specifically, we assessed random samples of issues from five major North American emergency medicine journals, including Annals of Emergency Medicine, Emergency Medicine, Canadian Journal of Emergency Medicine, Emergency Medicine Journal, and American Journal of Emergency Medicine. Five generalist medical journals were assessed including Journal of the American Medical Association, New England Journal of Medicine, Canadian Medical Association Journal, American Family Physician, and Canadian Family Physician. The volume of advertisements, nature of the claims, and cited evidence were collected by independent reviewers. The referenced evidence was assessed using the Oxford Centre for Evidence-Based Medicine Levels of Evidence rubric. Results: Of the 269 issues across the ten journals, opioid ads compromised 95 of the 3392 pharmaceutical advertisements with 79 opioid ads available for analysis. When analysis was completed with two reviewers, inter-rater agreement was rated as 99.87 (Cohen's kappa of 0.976). 37/79 ads did not mention the addictive potential of opioids, with 60/79 not mentioning the possibility of death. The tamper potential of medications was mentioned in 27/79 ads. Positive claims included efficacy (47/79), fast-acting ability (16/79), patient preference (5/79), convenience (26/79) and reduced side effects (22/79). 26/79 cited references directly in their text. Citations were provided for a total of 19 available original studies, of which a majority (16/19) were Level 2 evidence. Upon examination of conflicts of interest, 100% (19/19) of the referenced studies were funded by a pharmaceutical company. Conclusion: A variety of claims were published in medical journals through opioid advertisements, which cite industry studies. Many ads did not mention key negative information, which may have influenced EM physician prescribing.

Sign in / Sign up

Export Citation Format

Share Document